What is a stock summary page? Click here for an overview.
Business Description
Elutia Inc
NAICS : 339112
SIC : 5047
ISIN : US05479K1060
Share Class Description:
ELUT: Ordinary Shares - Class ADescription
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.54 | |||||
| Equity-to-Asset | -1.28 | |||||
| Debt-to-Equity | -0.54 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -12.31 | |||||
| Beneish M-Score | -3.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -43.1 | |||||
| 3-Year EBITDA Growth Rate | -1.6 | |||||
| 3-Year EPS without NRI Growth Rate | 26 | |||||
| 3-Year FCF Growth Rate | 19.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.12 | |||||
| 9-Day RSI | 47.61 | |||||
| 14-Day RSI | 46.43 | |||||
| 3-1 Month Momentum % | -3.53 | |||||
| 6-1 Month Momentum % | -13.91 | |||||
| 12-1 Month Momentum % | 6.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.69 | |||||
| Quick Ratio | 0.59 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 93.81 | |||||
| Days Sales Outstanding | 49.1 | |||||
| Days Payable | 105.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.5 | |||||
| Shareholder Yield % | -9.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.93 | |||||
| Operating Margin % | -99.62 | |||||
| Net Margin % | -221.33 | |||||
| FCF Margin % | -95.63 | |||||
| ROA % | -131.44 | |||||
| ROIC % | -62.35 | |||||
| 3-Year ROIIC % | -125.58 | |||||
| ROC (Joel Greenblatt) % | -3924.21 | |||||
| ROCE % | -3605.36 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.39 | |||||
| EV-to-EBIT | -2.53 | |||||
| EV-to-EBITDA | -2.72 | |||||
| EV-to-Revenue | 5.12 | |||||
| EV-to-FCF | -5.35 | |||||
| Price-to-GF-Value | 2.08 | |||||
| Earnings Yield (Greenblatt) % | -39.53 | |||||
| FCF Yield % | -19.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ELUT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elutia Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 24.375 | ||
| EPS (TTM) ($) | -2.47 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 81.2 | ||
| 14-Day RSI | 46.43 | ||
| 14-Day ATR ($) | 0.268774 | ||
| 20-Day SMA ($) | 2.88725 | ||
| 12-1 Month Momentum % | 6.49 | ||
| 52-Week Range ($) | 2.28 - 5.24 | ||
| Shares Outstanding (Mil) | 40.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Elutia Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Elutia Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Elutia Inc Frequently Asked Questions
What is Elutia Inc(ELUT)'s stock price today?
The current price of ELUT is $2.91. The 52 week high of ELUT is $5.24 and 52 week low is $2.28.
When is next earnings date of Elutia Inc(ELUT)?
The next earnings date of Elutia Inc(ELUT) is 2025-05-09 Est..
Does Elutia Inc(ELUT) pay dividends? If so, how much?
Elutia Inc(ELUT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers